Novel PCSK9 inhibitor lowers LDL-c in another large phase 3 study
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Anne Langsted, MD, PhD
Pasquale Perrone-Filardi, MD, PhD
Christie Ballantyne, MD
